Transporter-Mediated Drug Delivery.

Gyimesi, Gergely; Hediger, Matthias A (2023). Transporter-Mediated Drug Delivery. Molecules, 28(3) Molecular Diversity Preservation International MDPI 10.3390/molecules28031151

[img]
Preview
Text
molecules-28-01151-v2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Transmembrane transport of small organic and inorganic molecules is one of the cornerstones of cellular metabolism. Among transmembrane transporters, solute carrier (SLC) proteins form the largest, albeit very diverse, superfamily with over 400 members. It was recognized early on that xenobiotics can directly interact with SLCs and that this interaction can fundamentally determine their efficacy, including bioavailability and intertissue distribution. Apart from the well-established prodrug strategy, the chemical ligation of transporter substrates to nanoparticles of various chemical compositions has recently been used as a means to enhance their targeting and absorption. In this review, we summarize efforts in drug design exploiting interactions with specific SLC transporters to optimize their therapeutic effects. Furthermore, we describe current and future challenges as well as new directions for the advanced development of therapeutics that target SLC transporters.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Nephrologie / Hypertonie
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Gyimesi, Gergely (A), Hediger, Matthias

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1420-3049

Publisher:

Molecular Diversity Preservation International MDPI

Language:

English

Submitter:

Pubmed Import

Date Deposited:

13 Feb 2023 12:30

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.3390/molecules28031151

PubMed ID:

36770817

Uncontrolled Keywords:

SLC bile acids drug design membrane transporter nanoparticle pharmacokinetics prodrug solute carrier

BORIS DOI:

10.48350/178681

URI:

https://boris.unibe.ch/id/eprint/178681

Actions (login required)

Edit item Edit item
Provide Feedback